FIELD: biotechnology.
SUBSTANCE: invention is a method for diagnosing myopathy in an experiment involving the study of a test animal, characterized in that the content of the isoforms of NT- and N2A-titin is determined in the biceps muscle isolated from the forelimb, and when the conditions are fulfilled: the content of the NT isoform ≤0.016 and the content of the N2A isoform ≤0.085 diagnose myopathy.
EFFECT: increasing the reliability of diagnosis of myopathy by using specific laboratory indicators.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SIMULATING MYOPATHY | 2016 |
|
RU2632624C1 |
| METHOD OF DETERMINING RIGIDITY OF MUSCULAR FIBER COSTAMERE | 2008 |
|
RU2369332C1 |
| METHOD FOR SIMULATING OF ULCERATIVE COLITIS | 2015 |
|
RU2604044C1 |
| METHOD FOR SIMULATING GESTATIONAL PYELONEPHRITIS | 2013 |
|
RU2532402C1 |
| USE OF RHODANINE DERIVATIVE 3-(2-PHENYLETHYL)-2-THIOXO-1,3 THIAZOLIDIN-4-ONE FOR NORMALIZATION OF METABOLISM, INCREASE OF NON-SPECIFIC RESISTANCE, GROWTH AND DEVELOPMENT OF ANIMALS | 2019 |
|
RU2768456C2 |
| DIAGNOSTIC AGENT FOR POSITRON-EMISSION TOMOGRAPHY | 1997 |
|
RU2121368C1 |
| METHOD OF MODELLING MYOPIC EYE DISEASE | 2009 |
|
RU2405502C1 |
| NEXT GENERATION MEDICAL BIOLOGICAL ADHESIVE BASED ON BIOPOLYMER COMPOSITES AS SEMISYNTHETIC POLYMER MATRIXES WITH USING LASER TECHNOLOGIES | 2013 |
|
RU2543321C2 |
| DIAGNOSTIC TECHNIQUE FOR TRICHINOSIS IN EXPERIMENTALLY INFECTED LABORATORY ANIMALS | 2008 |
|
RU2384299C1 |
| COMPOSITIONS AND METHODS FOR CHARACTERISING MYOPATHY | 2011 |
|
RU2574932C2 |
